JAZZ vs NBIX
Jazz Pharmaceuticals vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | JAZZ | NBIX |
|---|---|---|
| AI Score | 53 | 63 |
| Price | — | — |
| P/E Ratio | 603.73× | 25.47× |
| ROE | -0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 1.0% |
| Debt / Equity | 1.20× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 66.1 | 45.1 |
| Beta | 0.324 | 0.386 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
JAZZ Full Analysis
NBIX Full Analysis